Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
David Manuel-Navarrete, Serena DeLuca, Fabio Friso & Matteo Politi. (2024) Ayahuasca ceremonies, relationality, and inner-outer transformations to sustainability. Evidence from Takiwasi Center in Peru. Ecosystems and People 20:1.
Read now
Read now
Miroslav Horák, Lea Hasíková & Nahanga Verter. (2018) Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic. Journal of Psychoactive Drugs 50:5, pages 430-436.
Read now
Read now
Joselaine Ida Cruz & Solange Aparecida Nappo. (2018) Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?. Journal of Psychoactive Drugs 50:3, pages 247-255.
Read now
Read now
Petr Winkler & Ladislav Csémy. (2014) Self-Experimentations with Psychedelics Among Mental Health Professionals: LSD in the Former Czechoslovakia. Journal of Psychoactive Drugs 46:1, pages 11-19.
Read now
Read now
Anja Loizaga-Velder & Rolf Verres. (2014) Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Substance Dependence—Qualitative Results. Journal of Psychoactive Drugs 46:1, pages 63-72.
Read now
Read now
Rafael Guimarães dos Santos. (2013) A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions. Journal of Psychoactive Drugs 45:2, pages 179-188.
Read now
Read now
Rafael Guimarães dos Santos. (2013) Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology. Journal of Psychoactive Drugs 45:1, pages 68-78.
Read now
Read now
Anette Kjellgren, Anders Eriksson & Torsten Norlander. (2009) Experiences of Encounters with Ayahuasca—“the Vine of the Soul”. Journal of Psychoactive Drugs 41:4, pages 309-315.
Read now
Read now
Stephen Trichter, Jon Klimo & Stanley Krippner. (2009) Changes in Spirituality Among Ayahuasca Ceremony Novice Participants. Journal of Psychoactive Drugs 41:2, pages 121-134.
Read now
Read now
Articles from other publishers (31)
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow & Rachel Yehuda. (2024) The Psychedelic Future of Post-Traumatic Stress Disorder Treatment. Current Neuropharmacology 22:4, pages 636-735.
Crossref
Crossref
José Carlos Bouso, Óscar Andión, Jerome J. Sarris, Milan Scheidegger, Luís Fernando Tófoli, Emérita Sátiro Opaleye, Violeta Schubert & Daniel Perkins. (2022) Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Global Public Health 2:11, pages e0000438.
Crossref
Crossref
Eduardo Ekman Schenberg & Konstantin Gerber. (2022) Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation. Transcultural Psychiatry 59:5, pages 610-624.
Crossref
Crossref
Steven A. Barker. (2022) Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. Psychopharmacology 239:6, pages 1749-1763.
Crossref
Crossref
Anne K Schlag, Jacob Aday, Iram Salam, Jo C Neill & David J Nutt. (2022) Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology 36:3, pages 258-272.
Crossref
Crossref
Evgenia Fotiou. (2019) The role of Indigenous knowledges in psychedelic science. Journal of Psychedelic Studies 4:1, pages 16-23.
Crossref
Crossref
Christian Sueur. (2018) État des lieux de la recherche sur les capacités thérapeutiques des « substances hallucinogènes » au 21 e siècle. Psychotropes Vol. 23:3, pages 125-163.
Crossref
Crossref
Matthew H. Bilhimer, Rachel F. Schult, Kristan V. Higgs, Timothy J. Wiegand, Rachel M. Gorodetsky & Nicole M. Acquisto. (2018) Acute Intoxication following Dimethyltryptamine Ingestion. Case Reports in Emergency Medicine 2018, pages 1-3.
Crossref
Crossref
Rafael Guimarães dos Santos, José Carlos Bouso & Jaime Eduardo Cecilio Hallak. (2017) Ayahuasca: what mental health professionals need to know. Archives of Clinical Psychiatry (São Paulo) 44:4, pages 103-109.
Crossref
Crossref
Benjamin J. Malcolm & Kelly C. Lee. (2017) Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?. Mental Health Clinician 7:1, pages 39-45.
Crossref
Crossref
Paulo Cesar Ribeiro Barbosa, Rick J. Strassman, Dartiu Xavier da Silveira, Kelsy Areco, Robert Hoy, Jessica Pommy, Robert Thoma & Michael Bogenschutz. (2016) Psychological and neuropsychological assessment of regular hoasca users. Comprehensive Psychiatry 71, pages 95-105.
Crossref
Crossref
Raven Renèe Ray & Kerry S. Lassiter. (2016) Ayahuasca Treatment Center Safety for the Western Seeker. Anthropology of Consciousness 27:2, pages 121-150.
Crossref
Crossref
Eduardo Ekman Schenberg, João Felipe Morel Alexandre, Renato Filev, Andre Mascioli Cravo, João Ricardo Sato, Suresh D. Muthukumaraswamy, Maurício Yonamine, Marian Waguespack, Izabela Lomnicka, Steven A. Barker & Dartiu Xavier da Silveira. (2015) Acute Biphasic Effects of Ayahuasca. PLOS ONE 10:9, pages e0137202.
Crossref
Crossref
Dimitrius L. Pitol, Selma Siéssere, Rafael G. dos Santos, Maria L. N. M. Rosa, Jaime E. C. Hallak, Priscilla H. Scalize, Bruno F. Pereira, Melina M. Iyomasa, Marisa Semprini, Jordi Riba & Simone C. H. Regalo. (2015) Ayahuasca Alters Structural Parameters of the Rat Aorta. Journal of Cardiovascular Pharmacology 66:1, pages 58-62.
Crossref
Crossref
Flávia de L. Osório, Rafael F. Sanches, Ligia R. Macedo, Rafael G. dos Santos, João P. Maia-de-Oliveira, Lauro Wichert-Ana, Draulio B. de Araujo, Jordi Riba, José A. Crippa & Jaime E. Hallak. (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Revista Brasileira de Psiquiatria 37:1, pages 13-20.
Crossref
Crossref
Janine Tatjana Schmid. 2014. The Therapeutic Use of Ayahuasca. The Therapeutic Use of Ayahuasca
77
93
.
Eduardo E Schenberg. (2013) Ayahuasca and cancer treatment. SAGE Open Medicine 1, pages 205031211350838.
Crossref
Crossref
Simon Gibbons & Warunya Arunotayanun. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
345
362
.
Paulo Cesar Ribeiro Barbosa, Suely Mizumoto, Michael P. Bogenschutz & Rick J. Strassman. (2012) Health status of ayahuasca users. Drug Testing and Analysis 4:7-8, pages 601-609.
Crossref
Crossref
Brian T. Anderson. (2012) Ayahuasca as Antidepressant? Psychedelics and Styles of Reasoning in Psychiatry. Anthropology of Consciousness 23:1, pages 44-59.
Crossref
Crossref
Ethan H. McIlhenny, Jordi Riba, Manel J. Barbanoj, Rick Strassman & Steven A. Barker. (2011) Methodology for determining major constituents of ayahuasca and their metabolites in blood. Biomedical Chromatography 26:3, pages 301-313.
Crossref
Crossref
Warunya Arunotayanun & Simon Gibbons. (2012) Natural product ‘legal highs’. Natural Product Reports 29:11, pages 1304.
Crossref
Crossref
Ethan H. McIlhenny, Jordi Riba, Manel J. Barbanoj, Rick Strassman & Steven A. Barker. (2010) Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Biomedical Chromatography 25:9, pages 970-984.
Crossref
Crossref
P.A. De Souza. (2011) Alcaloides e o chá de ayahuasca: uma correlação dos "estados alterados da consciência" induzido por alucinógenos. Revista Brasileira de Plantas Medicinais 13:3, pages 349-358.
Crossref
Crossref
Carolina Dizioli Rodrigues Oliveira, Camila Queiroz Moreira, Lilian Rose Marques de Sá, Helenice de Souza Spinosa & Mauricio Yonamine. (2010) Maternal and developmental toxicity of ayahuasca in Wistar rats. Birth Defects Research Part B: Developmental and Reproductive Toxicology 89:3, pages 207-212.
Crossref
Crossref
Ethan H. McIlhenny, Kelly E. Pipkin, Leanna J. Standish, Hope A. Wechkin, Rick Strassman & Steven A. Barker. (2009) Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography–electrospray ionization-tandem mass spectrometry. Journal of Chromatography A 1216:51, pages 8960-8968.
Crossref
Crossref
Ana Paula Salum Pires, Carolina Dizioli Rodrigues De Oliveira, Sidnei Moura, Felipe Augusto Dörr, Wagner Abreu E. Silva & Mauricio Yonamine. (2009)
Gas chromatographic analysis of dimethyltryptamine and
β
‐carboline alkaloids in ayahuasca, an amazonian psychoactive plant beverage
. Phytochemical Analysis 20:2, pages 149-153.
Crossref
Crossref
KENNETH W. TUPPER. (2008) Ayahuasca healing beyond the Amazon: the globalization of a traditional indigenous entheogenic practice. Global Networks 9:1, pages 117-136.
Crossref
Crossref
Kenneth W. Tupper. (2008) The globalization of ayahuasca: Harm reduction or benefit maximization?. International Journal of Drug Policy 19:4, pages 297-303.
Crossref
Crossref
Robert S. Gable. (2006) Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102:1, pages 24-34.
Crossref
Crossref
Débora González, Jordi Riba, José Carlos Bouso, Gregorio Gómez-Jarabo & Manel J. Barbanoj. (2006) Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence 85:2, pages 157-162.
Crossref
Crossref